SCL Science Acquires Logistics Business from Seoul Clinical Laboratories
On December 23, SCL Science, a digital healthcare specialist, announced that it will accelerate the expansion of its bio-logistics business by acquiring the Honam region bio-logistics operations from the Seoul Clinical Laboratories (SCL) Foundation.
This acquisition, valued at 4.3 billion won, follows SCL Science's earlier acquisition of the Yeongnam region bio-logistics business announced in July of this year. Bio-logistics is a core function of medical infrastructure, involving the transportation of specimens collected from medical institutions to testing laboratories under strict management.
A representative from SCL Science stated, "The company already possesses a computerized management system that meets the demands of the bio-logistics delivery market, where strict temperature control and timely delivery are crucial." The representative added, "We expect this business acquisition to generate an additional annual revenue of approximately 5 billion won."
The company previously announced in its quarterly report for September this year that it achieved its first-ever quarterly operating profit, reflecting the results of the acquired business. SCL Science plans to establish a sustainable profit structure through simultaneous growth in service areas and sales scale, and will continue to pursue high value-added business initiatives, including the advancement of bio-logistics services.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Based on its bio-logistics and digital capabilities, SCL Science is also building a comprehensive bio-platform that covers the entire healthcare sector, including advanced precision medical technologies such as cancer vaccines and genetic testing.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.